Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...
Dr. Richard Page answers the question: 'Are There Defibrillators Without Leads?' — -- Question: I have heard that some defibrillators may not need leads to be placed in the heart. Is this true, ...
The US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricle. This new 4.7 French (1.6mm) lead, which ...
CINNCINNATI, OH — A newly published case report describes a single incident where the Durata (St Jude Medical, St Paul, MN) lead failed at the time of high-voltage shock delivery in a patient with an ...
The OmniaSecure lead was placed in the desired right ventricular location in 99.5% of patients and achieved successful defibrillation testing at implantation in 97.5%. Freedom from study lead-related ...
A small-diameter, defibrillation lead that can be delivered through existing commercially available catheters for targeted placement is durable and safe, with no incidence of fractures at 1 year, the ...
The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...
Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced that it is monitoring a safety issue with Boston Scientific Corporation’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback